Clinical Trial for the Use of a Novel Cell Collector Device to Retrieve Cells From the Uterine Cervix

University Hospitals Cleveland Medical Center85 enrolled

Overview

This study tested the safety and performance of a new cell collector device and compared the results to those obtained with the current existing device that are being used routinely

This study tested the feasibility, safety and efficacy of the new e2TM Collector, and compared its performance with the standard method for obtaining cervical cells for Pap test of endocervical cytobrush and Ayer's Spatula

Study Type

OBSERVATIONAL

Enrollment

Conditions

Uterine Cervical Dysplasia Uterine Cervical Intraepithelial Neoplasia Uterine Cervical Neoplasia Uterine Cervical Cancer

Eligibility

Sex: FEMALEMin age: 14 Years

Medical Language ↔ Plain English

Inclusion Criteria: Women ages \>14 being followed for a previous abnormal Pap All patients will have signed an Informed Consent form prior to being enrolled in this study Exclusion Criteria: Patients who have had a hysterectomy

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.